Marché des dispositifs de test de crachat du cancer au Moyen-Orient et en Afrique, par type de produit (kits de collecte de salive, dispositifs spécifiques aux fluides, écouvillon buccal, étiquettes à code-barres, boîte de cryoconservation de salive et autres), site de collecte (glande sous-mandibulaire/sous-linguale, glande parotide et glande salivaire mineure), application (cancer du foie et du poumon, cancer du sein, cancer du côlon et du rectum, cancer de la prostate, cancer du pancréas, cancer de la bouche, cancer de la thyroïde, cancer de l'endomètre, cancer du rein, leucémie, mélanome, lymphome non hodgkinien et autres), groupe d'âge (adulte et pédiatrie), méthode de collecte (bave passive, écouvillon buccal et autres), utilisateur final (hôpitaux, laboratoires de diagnostic, cliniques spécialisées en oncologie, instituts de recherche sur le cancer et autres), canal de distribution (appels d'offres directs, ventes au détail et autres) Pays (Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël et reste du Moyen-Orient et de l'Afrique) Industrie Tendances et prévisions jusqu'en 2028.
Analyse et perspectives du marché : Marché des dispositifs de dépistage du cancer par crachat au Moyen-Orient et en Afrique
Le marché des dispositifs de test de crachat du cancer au Moyen-Orient et en Afrique devrait connaître une croissance significative au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 7,8% au cours de la période de prévision de 2021 à 2028 et devrait atteindre 34,95 millions USD d'ici 2028 contre 19,93 millions USD en 2020. La prévalence croissante des maladies chroniques et le nombre croissant de patients atteints de cancer sont les principaux moteurs qui devraient propulser la croissance du marché au cours de la période de prévision.
Le test salivaire est aujourd'hui largement utilisé pour détecter le cancer. Un test salivaire du cancer permet de détecter la présence ou l'absence d' ADN et d'ARN extracellulaires mutés . Les cellules tumorales libèrent de l'ADN et de l'ARN dans la circulation et ils pénètrent dans la salive. Les mutations sont détectables avec une grande précision dans la salive.
Le marché des dispositifs de test salivaire du cancer comprend des kits de test, des écouvillons , des cassettes et des dispositifs utilisés pour la détection de médicaments, d'infections ou de maladies chez l'homme. Plusieurs types de kits utilisent différents types de méthodes de biologie moléculaire pour la détection des maladies. ELISA, PCR, immuno-essai et dosages enzymatiques, entre autres, sont des techniques moléculaires utilisées pour les tests salivaires.
Le rapport sur le marché des dispositifs de test de dépistage du cancer au Moyen-Orient et en Afrique fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et localisé, analyse les opportunités en termes de poches de revenus émergentes, de changements dans la réglementation du marché, d'approbations de produits, de décisions stratégiques, de lancements de produits, d'expansions géographiques et d'innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché, contactez-nous pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché des dispositifs de test du cancer par crachat au Moyen-Orient et en Afrique
Middle East & Africa cancer spit test device market is segmented on the basis of product type, site of collection, application, age group, method of collection, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product type, the Middle East & Africa cancer spit test devices market is segmented into saliva collection kits, fluid specific devices, oral swab, bar-code labels, saliva cryostorage box, and others. In 2021, saliva collection kits segment is expected to dominate the market due to better patient compliance.
- On the basis of site of collection, the Middle East & Africa cancer spit test devices market is segmented into sub-mandibular/sub-lingual gland, parotid gland, and minor salivary gland. In 2021, sub-mandibular/sub-lingual gland segment is expected to dominate the market as it is an easy sample procurement method as compared to other conventional method.
- On the basis of application, the Middle East & Africa cancer spit test devices market is segmented into liver-lung cancer, breast cancer, colon and rectal cancer, prostate cancer, pancreatic cancer, oral cancer, thyroid cancer, endometrial cancer, kidney cancer, leukemia, melanoma, non-hodgkin lymphoma, and others. In 2021, liver-lung cancer segment is expected to dominate the market owing to rising prevalence of chronic and liver diseases.
- On the basis of age group, the Middle East & Africa cancer spit test devices market is segmented into adult and pediatrics. In 2021, adult segment is expected to dominate the market owing to rising growing geriatric population in the region.
- On the basis of method of collection, the Middle East & Africa cancer spit test devices market is segmented into passive drool, oral swab, and others. In 2021, passive drool segment is expected to dominate the market owing to its simple and non-invasive method of sample collection.
- On the basis of end user, the Middle East & Africa cancer spit test devices market is segmented into hospitals, diagnostic laboratories, oncology specialty clinics, cancer research institutes, and others. In 2021, hospitals segment is expected to dominate the market owing to rising number of cancer patients in the region.
- On the basis of distribution channel, the Middle East & Africa cancer spit test devices market is segmented into direct tender, retail sales, and others. In 2021, direct sales segment is expected to dominate the market owing to availability of a broad range of product offerings at reasonable cost.
Middle East & Africa Cancer Spit Test Devices Market Country Level Analysis
The Middle East & Africa cancer spit test devices market is analyzed and market size information is provided based on product type, site of collection, application, age group, method of collection, end user, and distribution channel.
Countries covered in the Middle East & Africa cancer spit test device market report are South Africa, Saudi Arabia, UAE, Egypt, Israel and Rest of Middle East and Africa. South Africa is expected to dominate the market due to increasing incidences of chronic diseases in the Middle East & Africa region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East & Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Rising Healthcare Expenditure and High Prevalence of Cancer are Creating New Opportunities for Players in the Middle East & Africa Cancer Spit Test Devices Market
Saliva collection kits segment in South Africa is expected to grow with the highest rate and it is dominating Middle East & Africa in the forecast period of 2021 to 2028 because of rising prevalence of cancer cases.
Middle East & Africa cancer spit test devices market also provides you with detailed market analysis for every country growth in particular industry with the Middle East & Africa cancer spit test device market sales, impact of advancement in the Middle East & Africa cancer spit test device market and changes in regulatory scenarios with their support for the Middle East & Africa cancer spit test devices market. The data is available for historic period 2010 to 2018.
Competitive Landscape and Middle East & Africa Cancer Spit Test Device Market Share Analysis
Middle East & Africa cancer spit test device market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to the Middle East & Africa cancer spit test devices market.
Les principaux acteurs couverts par le rapport sont DNA Genotek, Salimetrics, LLC, PeriRx, Color Health, Inc., SARSTEDT AG. Co. KG, Miraclean Technology Co., Ltd., Agilent Technologies, Inc., Illumina, Inc., QIAGEN, Thermo Fisher Scientific Inc., Abbott, BD, Biocartis, bioMérieux SA, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Oasis Diagnostics Corporation et Canvax (une filiale de dobuss) parmi d'autres acteurs nationaux et du Moyen-Orient et de l'Afrique. Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.
De nombreux lancements de produits et accords sont également initiés par les entreprises du monde entier, ce qui accélère encore la croissance du marché des dispositifs de test de crachat du cancer au Moyen-Orient et en Afrique.
Par exemple,
- En janvier 2021, DNA Genotek a annoncé que la Food and Drug Administration (FDA) des États-Unis avait accordé une autorisation d'utilisation générale 510(k) pour sa gamme de produits OrageneDx. Cette approbation de la FDA a renforcé la crédibilité de l'entreprise sur le marché.
- En février 2021, Thermo Fisher Scientific a reçu six CMO Leadership Awards. L'entreprise a remporté les six catégories, notamment les capacités, la compatibilité, l'expertise, la qualité, la fiabilité et le service. C'est la deuxième année consécutive que Thermo Fisher reçoit cette reconnaissance dans les six catégories et la huitième fois au total que l'entreprise est honorée par les CMO Leadership Awards. Cela a renforcé la crédibilité de l'entreprise et a contribué à la génération de revenus.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 REGULATORY FRAMEWORKS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN CANCER BURDEN WORLDWIDE
6.1.2 INCREASE IN INITIATIVES BY GOVERNMENT AND OTHER HEALTHCARE ORGANIZATIONS
6.1.3 RISE IN GERIATRIC POPULATION
6.1.4 RISE IN PRODUCT APPROVALS AND LAUNCHES FOR CANCER
6.1.5 RISE IN EXPENDITURE ON HEALTHCARE
6.2 RESTRAINTS
6.2.1 INCREASE PREVALENCE OF COVID-19
6.2.2 LACK OF EARLY DETECTION
6.3 OPPORTUNITIES
6.3.1 RECOMMENDATIONS FOR CANCER SCREENING
6.3.2 RISE IN DEMAND OF POINT-OF-CARE TESTING
6.3.3 RISE IN R&D ACTIVITIES
6.4 CHALLENGES
6.4.1 STRINGENT REGULATION POLICY
6.4.2 RISING COMPETITION AMONG MARKET PLAYERS
7 IMPACT OF COVID-19 THE ON MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET
7.1 IMPACT ON SUPPLY CHAIN
7.2 IMPACT ON DEMAND
7.3 STRATEGIC DECISIONS FOR MANUFACTURERS
7.4 CONCLUSION
8 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 SALIVA COLLECTION KIT
8.2.1 DNA EXTRACT
8.2.2 RNA EXTRACT
8.3 FLUID SPECIFIC DEVICES
8.4 ORAL SWAB
8.5 BAR-CODE LABELS
8.6 SALIVA CRYOSTORAGE BOX
8.7 OTHERS
9 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION
9.1 OVERVIEW
9.2 SUB-MANDIBULAR/SUB-LINGUAL GLAND
9.3 PAROTID GLAND
9.4 MINOR SALIVARY GLAND
10 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 LIVER-LUNG CANCER
10.3 BREAST CANCER
10.4 COLON AND RECTAL CANCER
10.5 PROSTATE CANCER
10.6 PANCREATIC CANCER
10.7 ORAL CANCER
10.8 THYROID CANCER
10.9 ENDOMETRIAL CANCER
10.1 KIDNEY CANCER
10.11 LEUKEMIA
10.12 MELANOMA
10.13 NON-HODGKIN LYMPHOMA
10.14 OTHERS
11 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP
11.1 OVERVIEW
11.2 ADULT
11.3 PEDIATRICS
12 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY METHOD OF COLLECTION
12.1 OVERVIEW
12.2 PASSIVE DROOL
12.3 ORAL SWAB
12.4 OTHERS
13 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.3 DIAGNOSTIC LABORATORIES
13.4 ONCOLOGY SPECIALITY CLINICS
13.5 CANCER RESEARCH INSTITUTES
13.6 OTHERS
14 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT TENDER
14.3 RETAIL SALES
14.4 OTHERS
15 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY REGION
15.1 MIDDLE EAST AND AFRICA
15.1.1 SOUTH AFRICA
15.1.2 SAUDI ARABIA
15.1.3 U.A.E.
15.1.4 EGYPT
15.1.5 ISRAEL
15.1.6 REST OF MIDDLE EAST AND AFRICA
16 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET: COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 BIOCARTIS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 BD
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENT
18.3 ABBOTT
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENT
18.4 F. HOFFMANN-LA ROCHE LTD
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENT
18.5 QIAGEN
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 AGILENT TECHNOLOGIES, INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 REVENUE ANALYSIS
18.6.3 PRODUCT PORTFOLIO
18.6.4 RECENT DEVELOPMENTS
18.7 BIOMÉRIEUX SA
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 CANVAX
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 COLOR HEALTH, INC.
18.9.1 1.6.1 COMPANY SNAPSHOT
18.9.2 1.6.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 DNA GENOTEK
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENT
18.11 ILLUMINA, INC.
18.11.1 COMPANY SNAPSHOT
18.11.2 REVENUE ANALYSIS
18.11.3 PRODUCT PORTFOLIO
18.11.4 RECENT DEVELOPMENTS
18.12 MIRACLEAN TECHNOLOGY CO.,LTD.
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENT
18.13 OASIS DIAGNOSTICS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 PRODUCT PORTFOLIO
18.13.3 RECENT DEVELOPMENT
18.14 PERIRX
18.14.1 COMPANY SNAPSHOT
18.14.2.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 SALIMETRICS, LLC
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 SARSTEDT AG & CO. KG
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)
18.17.1 COMPANY SNAPSHOT
18.17.2 REVENUE ANALYSIS
18.17.3 PRODUCT PORTFOLIO
18.17.4 RECENT DEVELOPMENTS
18.18 THERMO FISHER SCIENTIFIC INC.
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
Liste des tableaux
LIST OF TABLES
TABLE 1 NEW CANCER CASES, AGES 85+, IN THE U.S.
TABLE 2 DEATH CAUSES DUE TO CANCER, AGES 85+, IN THE U.S.
TABLE 3 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICE MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA FLUID SPECIFIC DEVICES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA BAR-CODE LABELS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA SALIVA CRYOSTORAGE BOX IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA SUB-MANDIBULAR/SUB-LINGUAL GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA PAROTID GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA MINOR SALIVARY GLAND IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA LIVER-LUNG CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA BREAST CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA COLON AND RECTAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA PROSTATE CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA PANCREATIC CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA ORAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA THYROID CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA ENDOMETRIAL CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA KIDNEY CANCER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA LEUKEMIA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA MELANOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA NON-HODGKIN LYMPHOMA IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA ADULT IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST AND AFRICA PEDIATRICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST AND AFRICA PASSIVE DROOL IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST AND AFRICA ORAL SWAB IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST AND AFRICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST AND AFRICA HOSPITALS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST AND AFRICA DIAGNOSTIC LABORATORIES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST AND AFRICA ONCOLOGY SPECIALITY CLINICS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST AND AFRICA CANCER RESEARCH INSTITUTES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 41 MIDDLE EAST AND AFRICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 42 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA DIRECT TENDER IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA RETAIL SALES IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA OTHERS IN CANCER SPIT TEST DEVICES MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 49 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 50 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 51 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 52 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 53 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 54 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 55 SOUTH AFRICA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 56 SOUTH AFRICA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 57 SOUTH AFRICA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 58 SOUTH AFRICA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 SOUTH AFRICA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 60 SOUTH AFRICA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 61 SOUTH AFRICA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 62 SOUTH AFRICA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 63 SAUDI ARABIA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 64 SAUDI ARABIA SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 65 SAUDI ARABIA CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 66 SAUDI ARABIA CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 SAUDI ARABIA CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 68 SAUDI ARABIA CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 69 SAUDI ARABIA CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 SAUDI ARABIA CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 U.A.E. CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 72 U.A.E. SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 73 U.A.E. CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 74 U.A.E. CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 U.A.E. CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 76 U.A.E. CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 77 U.A.E. CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 U.A.E. CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 79 EGYPT CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 80 EGYPT SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 81 EGYPT CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 82 EGYPT CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 83 EGYPT CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 84 EGYPT CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 85 EGYPT CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 86 EGYPT CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 87 ISRAEL CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 88 ISRAEL SALIVA COLLECTION KIT IN CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
TABLE 89 ISRAEL CANCER SPIT TEST DEVICES MARKET, BY SITE OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 90 ISRAEL CANCER SPIT TEST DEVICES MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 91 ISRAEL CANCER SPIT TEST DEVICES MARKET, BY AGE GROUP, 2019-2028 (USD MILLION)
TABLE 92 ISRAEL CANCER SPIT TEST DEVICES MARKET, BY METHOD OF COLLECTION, 2019-2028 (USD MILLION)
TABLE 93 ISRAEL CANCER SPIT TEST DEVICES MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 94 ISRAEL CANCER SPIT TEST DEVICES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 95 REST OF MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET, BY PRODUCT TYPE, 2019-2028 (USD MILLION)
Liste des figures
LIST OF FIGURES
FIGURE 1 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET : SEGMENTATION
FIGURE 11 THE INCREASING PREVALENCE OF CHRONIC DISEASES AND RISING HEALTHCARE EXPENDITURE ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 SALVIA COLLECTION KIT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET IN 2021 & 2028
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET
FIGURE 14 ESTIMATED NUMBER OF NEW CASES IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 15 ESTIMATED AGE-STANDARDIZED INCIDENCE RATES (WORLD) IN 2018, WORLDWIDE, BOTH SEXES, ALL AGES
FIGURE 16 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2020
FIGURE 17 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, 2021-2028 (USD MILLION)
FIGURE 18 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, CAGR (2021-2028)
FIGURE 19 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 20 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2020
FIGURE 21 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, 2021-2028 (USD MILLION)
FIGURE 22 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, CAGR (2021-2028)
FIGURE 23 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY SITE OF COLLECTION, LIFELINE CURVE
FIGURE 24 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2020
FIGURE 25 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 26 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 27 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 28 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2020
FIGURE 29 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, 2021-2028 (USD MILLION)
FIGURE 30 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, CAGR (2021-2028)
FIGURE 31 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 32 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2020
FIGURE 33 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, 2021-2028 (USD MILLION)
FIGURE 34 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, CAGR (2021-2028)
FIGURE 35 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY METHOD OF COLLECTION, LIFELINE CURVE
FIGURE 36 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: END USER, 2020
FIGURE 37 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: END USER, 2021-2028 (USD MILLION)
FIGURE 38 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: END USER, CAGR (2021-2028)
FIGURE 39 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: END USER, LIFELINE CURVE
FIGURE 40 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 41 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 42 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 43 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICE MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 44 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET: SNAPSHOT (2020)
FIGURE 45 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020)
FIGURE 46 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2021 & 2028)
FIGURE 47 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET: BY COUNTRY (2020 & 2028)
FIGURE 48 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET: BY PRODUCT TYPE (2021-2028)
FIGURE 49 MIDDLE EAST AND AFRICA CANCER SPIT TEST DEVICES MARKET: COMPANY SHARE 2020 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
